Trisomy 21 (Down syndrome) due to meiotic nondisjunction

Q17_TRISOMY_21_DUE_TO_MEIOTIC_NONDISJUNCTION

Endpoint definition

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 Q90.0
  • Cause of death: ICD-10 Q90.0

2 out of 7 registries used, show all original rules.

73

4. Check minimum number of events

None

73

5. Include endpoints

None

73

6. Filter based on genotype QC (FinnGen only)

68

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 68 42 26
Unadjusted period prevalence (%) 0.01 0.01 0.01
Median age at first event (years) 18.96 30.35 0.56

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
73
Matched controls
730
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q90.0
ICD-10 Finland
Trisomy 21, meiotic nondisjunction
+∞
104.9
73
*
Q90.9
ICD-10 Finland
Down syndrome, unspecified
+∞
56.9
47
*
Q90
ICD-10 Finland
Down syndrome
+∞
20.8
19
*
P85
ICPC
Mental retardation
61.6
19.6
22
5
7580A
ICD-9 Finland
Chromosomal anomalies, Down's syndrome
+∞
17.4
16
*
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
9.2
16.6
25
39
H65.3
ICD-10 Finland
Chronic mucoid otitis media
7.8
12.6
21
36
H03AA01
ATC
levothyroxine sodium; systemic
6.1
12.4
30
75
UDC00
NOMESCO Finland
Ear microscopy
10.9
10.8
21
26
Q21.21
ICD-10 Finland
Atrioventricular duct
63.8
9.9
11
*
Q21.10
ICD-10 Finland
Persistent ostium secundum
35.3
9.7
12
*
Q90.1
ICD-10 Finland
Trisomy 21, mosaicism (mitotic nondisjunction)
+∞
9.6
9
*
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
22.2
9.3
13
7
75930
ICD-8 Finland
Congenital syndromes affecting multiple systems, Down's disease
+∞
8.5
8
*
201
Kela drug reimbursment
Chronic cardiac insufficiency
17.6
8.0
12
8
Q25.0
ICD-10 Finland
Patent ductus arteriosus
21.2
7.9
11
6
H61.2
ICD-10 Finland
Impacted cerumen
10.3
6.9
13
15
Z01.1
ICD-10 Finland
Examination of ears and hearing
4.3
6.8
22
67
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
4.6
6.7
19
52
J18.9
ICD-10 Finland
Pneumonia, unspecified
4.1
6.6
23
74
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
6.8
6.5
16
29
F71
ICD-10 Finland
Moderate mental retardation
+∞
6.3
6
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
8.5
6.2
13
18
O35.1
ICD-10 Finland
Maternal care for (suspected) chromosomal abnormality in fetus
16.8
6.1
9
6

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
16
60
3.13
3.50
1.4
1.3
326.50
178.59
iu/ml
—
8
27
0
57
0.00
2.17
0.0
1.5
—
—
—
0
0
25
146
2.08
2.14
8.0
8.9
1.62
1.13
inr
—
5
42
6
15
4.26
2.08
1.2
1.0
—
—
—
0
0
32
211
1.92
1.92
2.0
1.6
13.40
2.65
u/ml
—
6
38
8
174
0.39
1.92
1.4
1.9
—
—
—
0
0
57
459
2.10
1.85
6.9
3.8
14.66
14.50
pmol/l
0.22
51
435
19
106
2.07
1.80
6.9
9.8
—
—
—
0
0
21
122
2.01
1.79
8.9
10.4
—
7.41
—
0
5
21
122
2.01
1.79
8.9
10.5
5.45
5.01
kpa
2.04
21
116
7
24
3.11
1.77
2.3
1.5
—
—
—
0
0
20
115
2.02
1.75
2.8
4.6
—
—
—
0
0
9
181
0.43
1.70
1.2
1.7
—
—
—
0
0
16
89
2.02
1.52
2.7
1.7
—
—
—
0
0
6
23
2.75
1.40
1.7
3.7
27.50
42.04
umol/l
—
6
23
0
40
0.00
1.37
0.0
1.5
—
—
—
0
0
18
111
1.83
1.27
9.1
10.1
8.79
9.25
kpa
0.79
18
106
15
87
1.91
1.27
1.5
1.3
—
—
—
0
0
46
369
1.67
1.25
5.7
8.3
0.55
0.58
e9/l
0.26
41
307
0
36
0.00
1.17
0.0
1.6
—
—
—
0
0
66
695
0.48
1.03
19.5
19.4
135.26
133.58
g/l
0.44
66
689
66
695
0.48
1.03
19.0
18.5
92.20
88.09
fl
6.15
66
689
66
695
0.48
1.03
18.9
18.4
31.05
29.50
pg
5.93
66
689
5
102
0.45
0.99
1.4
1.6
—
—
—
0
0
8
139
0.52
0.95
1.6
1.6
—
—
—
0
0
22
292
0.65
0.89
3.3
3.1
161.26
71.85
ug/l
0.59
22
281
21
150
1.56
0.86
1.7
1.8
83.83
95.42
pmol/l
—
7
87
12
78
1.64
0.71
3.9
2.5
332.58
332.75
nmol/l
0.00
12
73
39
330
1.39
0.65
6.5
12.2
5.91
6.16
mmol/l
0.51
39
300
8
49
1.71
0.65
1.3
1.3
—
—
—
0
0
10
64
1.65
0.62
1.2
1.8
—
—
—
0
0
0
20
0.00
0.61
0.0
1.2
—
—
—
0
0
0
22
0.00
0.60
0.0
1.2
—
0.12
—
0
16
6
97
0.58
0.57
1.3
1.4
—
—
—
0
0
46
408
1.34
0.53
6.3
12.4
3.64
3.69
e9/l
0.04
41
340
26
212
1.35
0.52
2.0
1.5
1.84
1.75
g/l
0.09
11
119
58
617
0.71
0.47
12.5
12.2
26.54
19.05
mg/l
0.73
48
444
24
198
1.32
0.44
3.4
6.8
—
—
—
0
0
15
115
1.38
0.43
3.5
11.1
1.35
1.35
mmol/l
0.01
15
110
39
345
1.28
0.42
7.0
9.6
—
—
—
0
0
14
178
0.74
0.40
1.7
2.1
—
—
—
0
0
24
201
1.29
0.39
4.3
8.8
35.73
36.81
g/l
0.72
24
195
56
591
0.77
0.33
15.5
16.9
14.54
14.06
%
0.41
56
585
14
171
0.78
0.30
2.9
3.7
—
—
—
0
0
11
139
0.75
0.30
2.5
3.2
2.12
2.69
mg/l
0.59
11
124
18
209
0.82
0.25
3.1
4.8
6.29
52.48
e6/l
1.02
12
132
15
125
1.25
0.25
8.3
18.3
25.76
24.09
mmol/l
1.58
15
125
15
126
1.24
0.23
2.5
2.4
—
—
—
0
0
15
176
0.81
0.23
1.6
1.7
—
—
—
0
0
12
98
1.27
0.23
3.1
12.7
23.67
23.21
mmol/l
0.18
12
98
0
11
0.00
0.21
0.0
10.9
—
876.45
—
0
11
0
11
0.00
0.21
0.0
13.6
—
1723.91
—
0
11
0
11
0.00
0.21
0.0
2.3
—
6.10
—
0
11
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
995.42
—
0
12
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
11
90
1.26
0.20
1.5
2.4
—
—
—
0
0
0
14
0.00
0.20
0.0
9.8
—
10.51
—
0
14
0
14
0.00
0.20
0.0
1.7
—
34.86
—
0
14
35
376
0.87
0.19
4.3
4.0
—
—
—
0
0
13
110
1.22
0.18
5.2
13.8
—
—
—
0
0
10
82
1.25
0.18
1.3
1.6
—
501.05
—
0
19
5
68
0.72
0.17
13.0
19.2
102.00
105.03
mmol/l
—
5
68
18
160
1.17
0.16
2.7
3.1
2.34
2.38
mmol/l
0.58
18
149
13
147
0.86
0.13
5.1
3.8
—
—
—
0
0
12
136
0.86
0.12
3.6
2.6
—
—
—
0
0
10
86
1.19
0.11
2.4
2.1
—
—
—
0
0
18
165
1.12
0.10
3.4
2.8
—
—
—
0
0
5
64
0.77
0.08
1.6
2.0
—
—
—
0
0
11
99
1.13
0.07
1.3
1.2
14.20
22.07
iu/ml
—
5
28
29
300
0.94
0.04
3.2
2.5
—
—
—
0
0
14
149
0.93
0.03
1.4
1.8
—
—
—
0
0
11
102
1.09
0.03
7.6
13.7
—
—
—
0
0
15
143
1.06
0.01
2.0
3.9
44.93
52.55
u/l
0.74
15
138
10
106
0.93
0.01
3.6
3.0
6.21
3.70
e6/l
—
10
94
32
319
1.01
0.00
5.6
11.0
0.43
0.00
e9/l
0.49
23
229
62
621
0.99
0.00
13.3
8.9
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.3
—
3.51
—
0
6
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
3.24
—
0
5
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
3.77
—
0
7
0
7
0.00
-0.00
0.0
40.9
—
175.14
—
0
7
0
6
0.00
-0.00
0.0
1.2
—
32.33
—
0
6
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
4.91
—
0
7
0
6
0.00
-0.00
0.0
1.0
—
33.38
—
0
6
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
6
67
0.89
-0.00
1.3
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.3
—
11.17
—
0
6
0
5
0.00
-0.00
0.0
2.4
—
66.80
—
0
5
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
1.86
—
0
5
0
5
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.6
—
1.03
—
0
5
0
5
0.00
-0.00
0.0
2.4
—
0.81
—
0
5
0
6
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
32.3
—
0.82
—
0
6
0
6
0.00
-0.00
0.0
2.2
—
7.03
—
0
6
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
5
56
0.89
-0.00
1.0
1.3
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

Index endpoint: Q17_TRISOMY_21_DUE_TO_MEIOTIC_NONDISJUNCTION – Trisomy 21 (Down syndrome) due to meiotic nondisjunction

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).